These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8745399)

  • 41. Think twice: understanding the high potency of bis(phenyl)methane inhibitors of thrombin.
    Baum B; Muley L; Heine A; Smolinski M; Hangauer D; Klebe G
    J Mol Biol; 2009 Aug; 391(3):552-64. PubMed ID: 19520086
    [TBL] [Abstract][Full Text] [Related]  

  • 42. X-ray crystal structures of thrombin in complex with D-Phe-Pro-Arg and with small benzamidine- and arginine-based "non-peptidic" inhibitors.
    Bode W
    Adv Exp Med Biol; 1993; 340():15-26. PubMed ID: 8154332
    [No Abstract]   [Full Text] [Related]  

  • 43. Structure of the hirulog 3-thrombin complex and nature of the S' subsites of substrates and inhibitors.
    Qiu X; Padmanabhan KP; Carperos VE; Tulinsky A; Kline T; Maraganore JM; Fenton JW
    Biochemistry; 1992 Dec; 31(47):11689-97. PubMed ID: 1445905
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular design and characterization of an alpha-thrombin inhibitor containing a novel P1 moiety.
    Malikayil JA; Burkhart JP; Schreuder HA; Broersma RJ; Tardif C; Kutcher LW; Mehdi S; Schatzman GL; Neises B; Peet NP
    Biochemistry; 1997 Feb; 36(5):1034-40. PubMed ID: 9033393
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human alpha-thrombin inhibition by the highly selective compounds N-ethoxycarbonyl-D-Phe-Pro-alpha-azaLys p-nitrophenyl ester and N-carbobenzoxy-Pro-alpha-azaLys p-nitrophenyl ester: a kinetic, thermodynamic and X-ray crystallographic study.
    De Simone G; Balliano G; Milla P; Gallina C; Giordano C; Tarricone C; Rizzi M; Bolognesi M; Ascenzi P
    J Mol Biol; 1997 Jun; 269(4):558-69. PubMed ID: 9217260
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structure of thrombin complexed with selective non-electrophilic inhibitors having cyclohexyl moieties at P1.
    Krishnan R; Mochalkin I; Arni R; Tulinsky A
    Acta Crystallogr D Biol Crystallogr; 2000 Mar; 56(Pt 3):294-303. PubMed ID: 10713516
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potent thrombin inhibitors that probe the S1 subsite: tripeptide transition state analogues based on a heterocycle-activated carbonyl group.
    Costanzo MJ; Maryanoff BE; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Kauffman JA; Lewis JM; Krishnan R; Tulinsky A
    J Med Chem; 1996 Aug; 39(16):3039-43. PubMed ID: 8759623
    [No Abstract]   [Full Text] [Related]  

  • 48. Crystal structures of thrombin complexed to a novel series of synthetic inhibitors containing a 5,5-trans-lactone template.
    Jhoti H; Cleasby A; Reid S; Thomas PJ; Weir M; Wonacott A
    Biochemistry; 1999 Jun; 38(25):7969-77. PubMed ID: 10387040
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The structure of residues 7-16 of the A alpha-chain of human fibrinogen bound to bovine thrombin at 2.3-A resolution.
    Martin PD; Robertson W; Turk D; Huber R; Bode W; Edwards BF
    J Biol Chem; 1992 Apr; 267(11):7911-20. PubMed ID: 1560020
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kinetic and crystallographic studies of thrombin with Ac-(D)Phe-Pro-boroArg-OH and its lysine, amidine, homolysine, and ornithine analogs.
    Weber PC; Lee SL; Lewandowski FA; Schadt MC; Chang CW; Kettner CA
    Biochemistry; 1995 Mar; 34(11):3750-7. PubMed ID: 7893672
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The methyl group of N(alpha)(Me)Arg-containing peptides disturbs the active-site geometry of thrombin, impairing efficient cleavage.
    Friedrich R; Steinmetzer T; Huber R; Stürzebecher J; Bode W
    J Mol Biol; 2002 Mar; 316(4):869-74. PubMed ID: 11884127
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Catalytically competent human and bovine zeta-thrombin and chimeras generated from unfolded polypeptide chains.
    Lewis SD; Brezniak DV; Fenton JW; Shafer JA
    Protein Sci; 1992 Aug; 1(8):998-1006. PubMed ID: 1304387
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Compounds binding to the S2-S3 pockets of thrombin.
    Nilsson M; Hämäläinen M; Ivarsson M; Gottfries J; Xue Y; Hansson S; Isaksson R; Fex T
    J Med Chem; 2009 May; 52(9):2708-15. PubMed ID: 19371038
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular modeling studies of novel retro-binding tripeptide active-site inhibitors of thrombin.
    Lau WF; Tabernero L; Sack JS; Iwanowicz EJ
    Bioorg Med Chem; 1995 Aug; 3(8):1039-48. PubMed ID: 7582978
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oxyanion-mediated inhibition of serine proteases.
    Presnell SR; Patil GS; Mura C; Jude KM; Conley JM; Bertrand JA; Kam CM; Powers JC; Williams LD
    Biochemistry; 1998 Dec; 37(48):17068-81. PubMed ID: 9836602
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structure of the non-covalent complex of prothrombin kringle 2 with PPACK-thrombin.
    Arni RK; Padmanabhan K; Padmanabhan KP; Wu TP; Tulinsky A
    Chem Phys Lipids; 1994 Jan; 67-68():59-66. PubMed ID: 8187245
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biochemical and crystallographic characterization of homologous non-peptidic thrombin inhibitors having alternate binding modes.
    Strickland CL; Fevig JM; Galemmo RA; Wells BL; Kettner CA; Weber PC
    Acta Crystallogr D Biol Crystallogr; 1998 Nov; 54(Pt 6 Pt 2):1207-15. PubMed ID: 10089499
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The ornithodorin-thrombin crystal structure, a key to the TAP enigma?
    van de Locht A; Stubbs MT; Bode W; Friedrich T; Bollschweiler C; Höffken W; Huber R
    EMBO J; 1996 Nov; 15(22):6011-7. PubMed ID: 8947023
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structure and behavior of human α-thrombin upon ligand recognition: thermodynamic and molecular dynamics studies.
    Silva Vde A; Cargnelutti MT; Giesel GM; Palmieri LC; Monteiro RQ; Verli H; Lima LM
    PLoS One; 2011; 6(9):e24735. PubMed ID: 21935446
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amidinohydrazones as guanidine bioisosteres: application to a new class of potent, selective and orally bioavailable, non-amide-based small-molecule thrombin inhibitors.
    Soll RM; Lu T; Tomczuk B; Illig CR; Fedde C; Eisennagel S; Bone R; Murphy L; Spurlino J; Salemme FR
    Bioorg Med Chem Lett; 2000 Jan; 10(1):1-4. PubMed ID: 10636229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.